Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1
Open Access
- 23 June 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (34) , 54515-54525
Abstract
Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1Keywords
This publication has 31 references indexed in Scilit:
- Trp53 Haploinsufficiency Modifies EGFR-Driven Peripheral Nerve Sheath TumorigenesisThe American Journal of Pathology, 2014
- Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancerGynecologic Oncology, 2014
- Adaptive Reprogramming of the Breast Cancer KinomeClinical Pharmacology & Therapeutics, 2014
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast CancerCell, 2012
- A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3Clinical Cancer Research, 2011
- Comprehensive analysis of kinase inhibitor selectivityNature Biotechnology, 2011
- p21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2PLOS ONE, 2010
- Differential expression analysis for sequence count dataGenome Biology, 2010
- Merlin, the Product of the Nf2 Tumor Suppressor Gene, Is an Inhibitor of the p21-Activated Kinase, Pak1Molecular Cell, 2003
- Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src.Molecular and Cellular Biology, 1994